Fungal antigens and process for producing the same
AssigneeTakara Shuzo Co., Ltd.
InventorsKazutoh Takesako, Shigetoshi Mizutani, Masahiro Endo, Ikunoshin Kato
Life of this patent
Estimating the term…
Abstract
There can be provided a fungal antigen which is an insoluble fraction obtainable from fungal cells of which cell wall has been substantially removed or at least partially removed; a process for producing the same; a nucleic acid encoding the fungal antigen; a biologic product containing the fungal antigen; a method of stimulating immunological responses by using the biologic product; a method of suppressing allergic reaction to fungi in a vertebrate; and a method for diagnosing a disease caused by fungi in a vertebrate.
Claims12
An isolated fungal antigen comprising an antigenic protein having a vaccine activity or an allergen activity wherein said isolated fungal antigen is originated from Candida albicans and said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 1 and has a molecular weight of about 65 kDa as determined by SDS-PAGE under reduced conditions.
An isolated fungal antigen comprising a protein having the amino acid sequence shown in SEQ. ID. NO. 5, said protein demonstrating antigenic properties as evaluated by at least one test selected from the group consisting of RAST, ELISA, histamine release test, skin test and intradermal test.
An isolated fungal antigen comprising an antigenic protein having a vaccine activity or an allergen activity originated from Candida albicans, wherein said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 2, and has a molecular weight of about 25 kDa as determined by SDS-PAGE under reduced conditions.
An isolated fungal antigen comprising a protein having the amino acid sequence of SEQ. ID. NO. 6, said peptide demonstrating antigenic properties as evaluated by at least one test selected from the group consisting of RAST, ELISA, histamine release test, skin test and intradermal test.
An isolated fungal antigen comprising an antigenic protein originated from Candida albicans, having a vaccine activity or an allergen activity, wherein said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 3, and has a molecular weight of about 30 kDa as determined by SDS-PAGE under reduced conditions.
An isolated fungal antigen comprising an antigenic protein originated from Candida albicans, having a vaccine activity or an allergen activity, wherein said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 4, and has a molecular weight of about 62 kDa as determined by SDS-PAGE under reduced conditions.
A pharmaceutical composition comprising an isolated fungal antigen comprising an antigenic protein having a vaccine activity or an allergen activity wherein said isolated fungal antigen originated from Candida albicans and said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 1 and has a molecular weight of about 65 kDa as determined by SDS-PAGE under reduced conditions.
A pharmaceutical composition comprising an isolated fungal antigen comprising a protein having the amino acid sequence shown in SEQ. ID. NO. 5, said protein demonstrating antigenic properties as evaluated by at least one test selected from the group consisting of RAST, ELISA, histamine release test, skin test and intradermal test.
A pharmaceutical composition comprising an isolated fungal antigen comprising an antigenic protein having a vaccine activity or an allergen activity originated from Candida albicans, wherein said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 2, and has a molecular weight of about 25 kDa as determined by SDS-PAGE under reduced conditions.
A pharmaceutical composition comprising an isolated fungal antigen comprising a protein having the amino acid sequence of SEQ. ID. NO. 6, said peptide demonstrating antigenic properties as evaluated by at least one test selected from the group consisting of RAST, ELISA, histamine release test, skin test and intradermal test.
A pharmaceutical composition comprising an isolated fungal antigen comprising an antigenic protein originated from Candida albicans, having a vaccine activity or an allergen activity, wherein said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 3, and has a molecular weight of about 30 kDa as determined by SDS-PAGE under reduced conditions.
A pharmaceutical composition comprising an isolated fungal antigen comprising an antigenic protein originated from Candida albicans, having a vaccine activity or an allergen activity, wherein said antigenic protein comprises the amino acid sequence of SEQ. ID. NO. 4, and has a molecular weight of about 62 kDa as determined by SDS-PAGE under reduced conditions.
Dependencies are inferred from the claim text.